Another Activist Investor Joins Calls For GSK Leadership Review
Bluebell Capital Has Already Ousted One CEO
A second activist investor has called for GSK to consider replacing Emma Walmsley as CEO, and has underlined competitive threats to a key pipeline candidate.
